Literature DB >> 23986495

Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex.

Liam Baird1, David Llères, Sam Swift, Albena T Dinkova-Kostova.   

Abstract

The transcription factor NF-E2 p45-related factor 2 (Nrf2), a master regulator of cytoprotective genes, is controlled by dimeric Kelch-like ECH associated protein 1 (Keap1), a substrate adaptor protein for Cullin3/RING-box protein 1 ubiquitin ligase, which normally targets Nrf2 for ubiquitination and degradation but loses this ability in response to electrophiles and oxidants (inducers). By using recombinant proteins and populations of cells, some of the general features of the regulation of Nrf2 by Keap1 have been outlined. However, how the two proteins interact at a single-cell level is presently unknown. We now report the development of a quantitative Förster resonance energy transfer-based system using multiphoton fluorescence lifetime imaging microscopy and its application for investigating the interaction between Nrf2 and Keap1 in single live cells. By using this approach, we found that under homeostatic conditions, the interaction between Keap1 and Nrf2 follows a cycle in which the complex sequentially adopts two distinct conformations: "open," in which Nrf2 interacts with a single molecule of Keap1, followed by "closed," in which Nrf2 binds to both members of the Keap1 dimer. Inducers disrupt this cycle by causing accumulation of the complex in the closed conformation without release of Nrf2. As a consequence, free Keap1 is not regenerated, and newly synthesized Nrf2 is stabilized. On the basis of these findings, we propose a model we have named the "cyclic sequential attachment and regeneration model of Keap1-mediated degradation of Nrf2." This previously unanticipated dynamism allows rapid transcriptional responses to environmental changes and can accommodate multiple modes of regulation.

Entities:  

Keywords:  FLIM; FRET; protein–protein interactions; sulforaphane

Mesh:

Substances:

Year:  2013        PMID: 23986495      PMCID: PMC3780858          DOI: 10.1073/pnas.1305687110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.

Authors:  Donna D Zhang; Mark Hannink
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

Review 3.  Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.

Authors:  John D Hayes; Michael McMahon; Sudhir Chowdhry; Albena T Dinkova-Kostova
Journal:  Antioxid Redox Signal       Date:  2010-08-14       Impact factor: 8.401

Review 4.  RING domain E3 ubiquitin ligases.

Authors:  Raymond J Deshaies; Claudio A P Joazeiro
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response.

Authors:  Weimin Chen; Zheng Sun; Xiao-Jun Wang; Tao Jiang; Zheping Huang; Deyu Fang; Donna D Zhang
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

6.  Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.

Authors:  Aimee L Eggler; Guowen Liu; John M Pezzuto; Richard B van Breemen; Andrew D Mesecar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

7.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1.

Authors:  Masaaki Komatsu; Hirofumi Kurokawa; Satoshi Waguri; Keiko Taguchi; Akira Kobayashi; Yoshinobu Ichimura; Yu-Shin Sou; Izumi Ueno; Ayako Sakamoto; Kit I Tong; Mihee Kim; Yasumasa Nishito; Shun-ichiro Iemura; Tohru Natsume; Takashi Ueno; Eiki Kominami; Hozumi Motohashi; Keiji Tanaka; Masayuki Yamamoto
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

8.  Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1.

Authors:  Akira Kobayashi; Moon-Il Kang; Yoriko Watai; Kit I Tong; Takahiro Shibata; Koji Uchida; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

9.  Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome.

Authors:  Truyen Nguyen; Philip J Sherratt; H-C Huang; Chung S Yang; Cecil B Pickett
Journal:  J Biol Chem       Date:  2002-11-22       Impact factor: 5.157

10.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.

Authors:  Gina M DeNicola; Florian A Karreth; Timothy J Humpton; Aarthi Gopinathan; Cong Wei; Kristopher Frese; Dipti Mangal; Kenneth H Yu; Charles J Yeo; Eric S Calhoun; Francesca Scrimieri; Jordan M Winter; Ralph H Hruban; Christine Iacobuzio-Donahue; Scott E Kern; Ian A Blair; David A Tuveson
Journal:  Nature       Date:  2011-07-06       Impact factor: 49.962

View more
  110 in total

1.  Coordinated regulation of Nrf2 and histone H3 serine 10 phosphorylation in arsenite-activated transcription of the human heme oxygenase-1 gene.

Authors:  Paul D Ray; Bo-Wen Huang; Yoshiaki Tsuji
Journal:  Biochim Biophys Acta       Date:  2015-08-18

Review 2.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

3.  Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats.

Authors:  June K Dunnick; Keith R Shockley; Daniel L Morgan; Amy Brix; Gregory S Travlos; Kevin Gerrish; J Michael Sanders; T V Ton; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2016-09-16       Impact factor: 5.153

Review 4.  Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.

Authors:  B G Richardson; A D Jain; T E Speltz; T W Moore
Journal:  Bioorg Med Chem Lett       Date:  2015-04-16       Impact factor: 2.823

Review 5.  Reductive stress in striated muscle cells.

Authors:  Ilaria Bellezza; Francesca Riuzzi; Sara Chiappalupi; Cataldo Arcuri; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Cell Mol Life Sci       Date:  2020-02-18       Impact factor: 9.261

6.  Non-covalent NRF2 Activation Confers Greater Cellular Protection than Covalent Activation.

Authors:  Pengfei Liu; Wang Tian; Shasha Tao; Joseph Tillotson; E M Kithsiri Wijeratne; A A Leslie Gunatilaka; Donna D Zhang; Eli Chapman
Journal:  Cell Chem Biol       Date:  2019-08-08       Impact factor: 8.116

7.  p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex.

Authors:  Shasha Tao; Pengfei Liu; Gang Luo; Montserrat Rojo de la Vega; Heping Chen; Tongde Wu; Joseph Tillotson; Eli Chapman; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2017-03-31       Impact factor: 4.272

Review 8.  Metabolic switching and cell fate decisions: implications for pluripotency, reprogramming and development.

Authors:  Tim S Cliff; Stephen Dalton
Journal:  Curr Opin Genet Dev       Date:  2017-07-04       Impact factor: 5.578

9.  Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors.

Authors:  Meng-Chen Lu; Shi-Jie Tan; Jian-Ai Ji; Zhi-Yun Chen; Zhen-Wei Yuan; Qi-Dong You; Zheng-Yu Jiang
Journal:  ACS Med Chem Lett       Date:  2016-07-05       Impact factor: 4.345

10.  Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.

Authors:  Annette Liessem-Schmitz; Nico Teske; Miriam Scheld; Stella Nyamoya; Adib Zendedel; Cordian Beyer; Tim Clarner; Athanassios Fragoulis
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.